Cargando…
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
Infection caused by the four serotypes of dengue virus (DENV-1-4) is a leading cause of mosquito-borne disease. Clinically-severe dengue disease is more common when secondary dengue infection occurs following prior infection with a heterologous dengue serotype. Other flaviviruses such as yellow feve...
Autores principales: | Whitehead, Stephen S., Durbin, Anna P., Pierce, Kristen K., Elwood, Dan, McElvany, Benjamin D., Fraser, Ellen A., Carmolli, Marya P., Tibery, Cecilia M., Hynes, Noreen A., Jo, Matthew, Lovchik, Janece M., Larsson, Catherine J., Doty, Elena A., Dickson, Dorothy M., Luke, Catherine J., Subbarao, Kanta, Diehl, Sean A., Kirkpatrick, Beth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436874/ https://www.ncbi.nlm.nih.gov/pubmed/28481883 http://dx.doi.org/10.1371/journal.pntd.0005584 |
Ejemplares similares
-
Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003
por: Tu, Huy A., et al.
Publicado: (2020) -
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue
por: Sáez-Llorens, Xavier, et al.
Publicado: (2023) -
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014) -
Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine
por: Izmirly, Abdullah M., et al.
Publicado: (2022) -
97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View
por: Tricou, Vianney, et al.
Publicado: (2021)